12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Myriad Genetics sales and marketing update

Myriad Genetics launched Panexia in the U.S. to assess the risk of developing pancreatic cancer later in life....

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >